UgonmaChukwuekeMD

PubMed

• 2 citations
  Re-irradiation of recurrent IDH-wildtype glioblastoma in the bevacizumab and immunotherapy era: Target delineation, outcomes and patterns of recurrence.
  Christ, S., Youssef, G., Shi, D., McFaline-Figueroa, J., Hertler, C., Andratschke, N., Weller, M., Guckenberger, M., Tanguturi, S., Cagney, D., Chukwueke, U., Lee, E.,...> ;Clinical and Translational Radiation Oncology. 2024 Jan 1
• Defining interventions and metrics to improve diversity in CNS clinical trial participation: A SNO and RANO effort.
  Joshua A Budhu, Ugonma N Chukwueke, Sadhana Jackson, Eudocia Q Lee, J Ricardo McFaline-Figueroa, Nicole Willmarth, Mahalia Dalmage, Ichiro Kawachi, David Arons, Susan ...> ;Neuro-Oncology. 2024 Apr 5
• Disparities in Neuro-Oncology.
  Nara Miriam Michaelson, Amanda Watsula, Anu Bakare-Okpala, Maliheh Mohamadpour, Ugonma N Chukwueke, Joshua A Budhu> ;Current Neurology and Neuroscience Reports. 2023 Dec 1
• 12 citations
  Clinical trial links oncolytic immunoactivation to survival in glioblastoma.
  Alexander L Ling, Isaac H Solomon, Ana Montalvo Landivar, Hiroshi Nakashima, Jared K Woods, Andres Santos, Nafisa Masud, Geoffrey Fell, Xiaokui Mo, Ayse S Yilmaz, Jame...> ;Nature. 2023 Nov 1
• 1 citations
  Validation of targeted next-generation sequencing of cell-free DNA from archival cerebrospinal fluid specimens for the detection of somatic variants in cancer involvin...
  Alexander J Neil, Ugonma N Chukwueke, Nicholas Hoover, Sean R N Marris, Vanesa Rojas-Rudilla, Danielle K Manning, Jeffrey K Mito, Edmund S Cibas, Lynette M Sholl> ;Cancer Cytopathology. 2024 Apr 1
• 3 citations
  Inaugural Results of the Individualized Screening Trial of Innovative Glioblastoma Therapy: A Phase II Platform Trial for Newly Diagnosed Glioblastoma Using Bayesian A...
  Rifaquat Rahman, Lorenzo Trippa, Eudocia Q Lee, Isabel Arrillaga-Romany, Geoffrey Fell, Mehdi Touat, Christine McCluskey, Jennifer Wiley, Sarah Gaffey, Jan Drappatz, M...> ;Journal of Clinical Oncology. 2023 Dec 20
• 3 citations
  Clinical efficacy and safety of chimeric antigen receptor T-cell therapy for mantle cell lymphoma with secondary central nervous system involvement.
  Christine E Ryan, Rebecca L Zon, Robert Redd, David C Fisher, Roni Shouval, Anita Kumar, Jennifer L Crombie, Hossein Sadrzadeh, Austin I Kim, Lakshmi Nayak, Ugonma N C...> ;British Journal of Haematology. 2023 Dec 1
• 2 citations
  Evaluating hematologic parameters in newly diagnosed and recurrent glioblastoma: Prognostic utility and clinical trial implications of myelosuppression.
  Davy Deng, Lubna Hammoudeh, Gilbert Youssef, Yu-Hui Chen, Kee-Young Shin, Mary Jane Lim-Fat, Jose Ricardo McFaline-Figueroa, Ugonma N Chukwueke, Shyam Tanguturi, David...> ;Neuro-Oncology Advances. 2023 Jul 8
• 3 citations
  Bavituximab Decreases Immunosuppressive Myeloid-Derived Suppressor Cells in Newly Diagnosed Glioblastoma Patients.
  K Ina Ly, Leland G Richardson, Mofei Liu, Alona Muzikansky, Jonathan Cardona, Kevin Lou, Andrew L Beers, Ken Chang, James M Brown, Xiaoyue Ma, David A Reardon, Isabel ...> ;Clinical Cancer Research. 2023 Aug 15
• 69 citations
  World Health Organization 2021 Classification of Central Nervous System Tumors and Implications for Therapy for Adult-Type Gliomas: A Review.
  Tamar R Berger, Patrick Y Wen, Melanie Lang-Orsini, Ugonma N Chukwueke> ;JAMA Oncology. 2022 Oct 1
• 32 citations
  Phase 2 study of pembrolizumab in patients with recurrent and residual high-grade meningiomas.
  Priscilla K Brastianos, Albert E Kim, Anita Giobbie-Hurder, Eudocia Quant Lee, Nancy Wang, April F Eichler, Ugonma Chukwueke, Deborah A Forst, Isabel C Arrillaga-Roman...> ;Nature Communications. 2022 Mar 14
• 7 citations
  Primary Central Nervous System Lymphomas.
  Ugonma Chukwueke, Christian Grommes, Lakshmi Nayak> ;Hematology/oncology Clinics of North America. 2022 Feb 1
• 4 citations
  Disparities and Inequities Among Patients with Central Nervous System Tumor.
  Ugonma Chukwueke, Shawn L. Hervey-Jumper, Alyx B. Porter> ;Hematology/oncology Clinics of North America. 2022 Feb 1
• 7 citations
  A population study of clinical trial accrual for women and minorities in neuro-oncology following the NIH Revitalization Act.
  Sheantel J Reihl, Nirav Patil, Ramin A Morshed, Mulki Mehari, Alexander Aabedi, Ugonma N Chukwueke, Alyx B Porter, Valy Fontil, Gino Cioffi, Kristin Waite, Carol Kruch...> ;Neuro-Oncology. 2022 Aug 1
• 15 citations
  Clinical utility of targeted next-generation sequencing assay in IDH-wildtype glioblastoma for therapy decision-making.
  Mary Jane Lim-Fat, Gilbert C Youssef, Mehdi Touat, J Bryan Iorgulescu, Sydney Whorral, Marie Allen, Rifaquat Rahman, Ugonma Chukwueke, J Ricardo McFaline-Figueroa, Lak...> ;Neuro-Oncology. 2022 Jul 1
• Author Correction: Genomic and transcriptomic correlates of immunotherapy response within the tumor microenvironment of leptomeningeal metastases.
  Sanjay M. Prakadan, Christopher Alvarez-Breckenridge, Samuel Markson, Albert E. Kim, Robert H. Klein, Naema Nayyar, Andrew W. Navia, Benjamin M. Kuter, Kellie E. Kolb,...> ;Nature Communications. 2021 Nov 25
• 35 citations
  Phase II study of ipilimumab and nivolumab in leptomeningeal carcinomatosis.
  Priscilla K. Brastianos, Matthew R. Strickland, Eudocia Q. Lee, Nancy Wang, Justine V. Cohen, Ugonma Chukwueke, Deborah Forst, April F. Eichler, Beth Overmoyer, Nan Li...> ;Nature Communications. 2021 Oct 12
• 23 citations
  Genomic and transcriptomic correlates of immunotherapy response within the tumor microenvironment of leptomeningeal metastases
  Sanjay M. Prakadan, Christopher Alvarez-Breckenridge, Samuel Markson, Albert E. Kim, Robert H. Klein, Naema Nayyar, Andrew W. Navia, Benjamin M. Kuter, Kellie E. Kolb,...> ;Nature Communications. 2021 Oct 12
• 5 citations
  SNO 2020 diversity survey: defining demographics, racial biases, career success metrics and a path forward for the field of neuro-oncology
  Ugonma Chukwueke, Elizabeth Vera, Alvina Acquaye, Shawn L. Hervey-Jumper, Yazmin Odia, Laura J. Klesse, Erin M. Dunbar, Akanksha Sharma, Ekokobe Fonkem, Alissa A. Thom...> ;Neuro-Oncology. 2021 Nov 2
• 39 citations
  Activity of PD-1 blockade with Nivolumab among patients with recurrent atypical/anaplastic meningioma: Phase II trial results.
  Wenya Linda Bi, Lakshmi Nayak, David Meredith, Joseph Driver, Ziming Du, Samantha E Hoffman, Yvonne Y. Li, Eudocia Q. Lee, Rameen Beroukhim, Mikael L. Rinne, Ricardo M...> ;Neuro-Oncology. 2021 May 20
• 23 citations
  Palbociclib demonstrates intracranial activity in progressive brain metastases harboring cyclin-dependent kinase pathway alterations
  Priscilla K. Brastianos, Albert E. Kim, Nancy Wang, Eudocia Q. Lee, Jennifer A. Ligibel, Justine V. Cohen, Ugonma Chukwueke, Maura Mahar, Kevin S. Oh, Michael White, H...> ;Nature Cancer. 2021 May 1
• 6 citations
  Delivering Equitable Care to Underserved Neuro-oncology Populations.
  Alyx B. Porter, Ugonma Chukwueke, Aaron Mammoser, Bret Edward Buckley Friday, Shawn L. Hervey-Jumper> ;American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting. 2021 Apr 8
• 13 citations
  Socioeconomic Disparities Associated With MGMT Promoter Methylation Testing for Patients With Glioblastoma.
  Nayan Lamba, Ugonma Chukwueke, Timothy R. Smith, Keith L. Ligon, Ayal A. Aizer, David A. Reardon, J. Bryan Iorgulescu> ;JAMA Oncology. 2020 Dec 1
• 4 citations
  Publisher Correction: Single-arm, open-label phase 2 trial of pembrolizumab in patients with leptomeningeal carcinomatosis.
  Priscilla K. Brastianos, Eudocia Q. Lee, Justine V. Cohen, Sara M. Tolaney, Nan Lin, Nancy Wang, Ugonma Chukwueke, Michael White, Naema Nayyar, Albert H. Kim, Christop...> ;Nature Medicine. 2020 Aug 1
• 7 citations
  Advances in Management of Brain and Leptomeningeal Metastases
  Vyshak Alva Venur, Ugonma Chukwueke, Eudocia Q. Lee> ;Current Neurology and Neuroscience Reports. 2020 Jun 6
• Join now to see all